Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10012862HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10013143HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10013617HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10010335HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10008296HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10009822HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10010595HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10012467HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10013618HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10007908HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TCGA Plot Options
Drug Information
GenePDE3A
DrugBank IDDB00922
Drug NameLevosimendan
Target IDBE0000436
UniProt IDQ14432
Regulation Typeinhibitor
PubMed IDs16116344
CitationsSzilagyi S, Pollesello P, Levijoki J, Haikala H, Bak I, Tosaki A, Borbely A, Edes I, Papp Z: Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone. J Cardiovasc Pharmacol. 2005 Sep;46(3):369-76.
GroupsApproved; Investigational
Direct ClassificationPhenylhydrazines
SMILESC[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1
Pathways
PharmGKBPA164749138
ChEMBLCHEMBL2051955